TransUnion Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TransUnion on February 22, 2022. The filing primarily announces the results of operations for the quarter and full year ended December 31, 2021, and discloses a significant new acquisition. The Company completed the divestiture of its Healthcare business on December 17, 2021, with results now reported as discontinued operations.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) and earnings presentation (Exhibit 99.4) containing specific revenue, profit, cash flow, and margin data for the period ended December 31, 2021. However, the body of this 8-K filing does not explicitly state these numerical values. It notes that historical periods have been recast to exclude the Healthcare business.
Material Changes and Transactions
- Divestiture: Completed the sale of the Healthcare business on December 17, 2021. Financial statements have been recast to reflect this as discontinued operations.
- Acquisition: Entered into a definitive agreement to acquire Verisk Financial Services, the financial services business unit of Verisk Analytics, Inc.
- Acquisition Terms: The purchase price is $515 million in cash, subject to customary adjustments.
- Closing Timeline: The transaction is expected to close in the second quarter of 2022, pending regulatory approval and customary closing conditions.
Guidance, Outlook, and Risks
Management reviewed fiscal 2021 fourth-quarter earnings materials during a conference call on February 22, 2022. The filing states that the Company undertakes no duty to update or revise the information contained in the presentation materials. The acquisition of Verisk Financial Services is subject to regulatory approval, including the expiration of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2021 revenue, earnings, and cash flow figures.
- Examine Exhibit 99.2 for the schedule of recast historical financial information excluding the Healthcare divestiture.
- Verify the status of regulatory approvals required for the $515 million acquisition of Verisk Financial Services.
- Confirm the expected closing date in Q2 2022 and any potential purchase price adjustments.